Citigroup Inc. Lowers Position in The Clorox Company (NYSE:CLX)

Citigroup Inc. decreased its position in The Clorox Company (NYSE:CLX - Free Report) by 23.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 145,280 shares of the company's stock after selling 44,860 shares during the period. Citigroup Inc. owned about 0.12% of Clorox worth $23,668,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. Prospera Private Wealth LLC purchased a new stake in shares of Clorox during the third quarter worth $27,000. Innealta Capital LLC purchased a new stake in shares of Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC lifted its position in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Family Firm Inc. purchased a new stake in shares of Clorox during the second quarter worth $31,000. Finally, Quarry LP lifted its position in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after acquiring an additional 114 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Up 0.6 %

CLX opened at $167.34 on Wednesday. The stock has a market cap of $20.71 billion, a PE ratio of 58.31, a P/E/G ratio of 3.13 and a beta of 0.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.35. The business's fifty day simple moving average is $162.84 and its 200 day simple moving average is $148.88.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 earnings per share. The firm's revenue was up 27.0% on a year-over-year basis. As a group, research analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 2.92%. Clorox's payout ratio is 170.03%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. JPMorgan Chase & Co. increased their target price on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research report on Friday, October 11th. Deutsche Bank Aktiengesellschaft increased their target price on Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a report on Monday, November 4th. Barclays upped their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a report on Friday, November 1st. Finally, TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and upped their price target for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $155.00.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.57% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.